These S&P500 stocks are gapping in today's session
By Mill Chart
Last update: May 13, 2025
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the S&P500 gap up and gap down stocks in today's session.
Top gap down stocks
| Ticker | Change | Comment |
|---|---|---|
| UNH | -13.09% | UNITEDHEALTH GROUP INC's (NYSE:UNH) stock price is declining with 13.09% to a price of $329.18 with a gap of 16.69%. Earlier today the company had a press release: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UnitedHealth Group Incorporated of Class Action Lawsuit and Upcoming Deadlines - UNH. |
| ELV | -5.81% | ELEVANCE HEALTH INC's (NYSE:ELV) shares recorded a 5.81% decline to $392.5, with a notable 9.75% gap during today's session. Shareholders saw the stock price going 23.92% lower is the past year. |
| HUM | -5.78% | Unfavorable news for HUMANA INC's (NYSE:HUM) stock! It witnessed a 5.78% decline to $238.25 in today's session, along with a 8.41% gap. In the last year the stock lost 29.01%. |
| ENPH | -5.4% | ENPHASE ENERGY INC's (NASDAQ:ENPH) stock price is declining with 5.4% to a price of $45.35 with a gap of 19.18%. The stock is trading 25.02% lower than 3 months ago. |
| SPG | -4.49% | SIMON PROPERTY GROUP INC's (NYSE:SPG) stock price decreased by 4.49% to $163.75 with a gap of 6.07%. |
| CNC | -4.33% | CENTENE CORP's (NYSE:CNC) shares fell 4.33% to $60.15 with a gap of 6.47%. |
| CVS | -3.98% | CVS HEALTH CORP's (NYSE:CVS) stock price decreased by 3.98% to $62.23 with a gap of 7.61%. In the last 6 months the stock gained 21.85%. |
| DVA | -3.69% | Unfavorable news for DAVITA INC's (NYSE:DVA) stock! It witnessed a 3.69% decline to $139.1 in today's session, along with a 7.25% gap. |
| HSY | -3.3% | HERSHEY CO/THE's (NYSE:HSY) shares fell 3.3% to $162.05 during Tuesday's session with a gap of 5.95%. |
| MRK | -3.26% | MERCK & CO. INC.'s (NYSE:MRK) stock price is declining with 3.26% to a price of $77.81 with a gap of 5.54%. A press release (Research on Novel Treatment Approaches and Scientific Advances From Merck’s Broad and Differentiated Oncology Portfolio and Pipeline to be Presented at ASCO 2025) was released earlier today. |
For the full top loser list go to our gap down stocks screener.
184.27
-3.23 (-1.72%)
164.93
-1.42 (-0.85%)
80.69
+0.32 (+0.4%)
25.59
+0.33 (+1.31%)
266.68
+10.54 (+4.11%)
250.89
+6.22 (+2.54%)
129.5
+1.81 (+1.42%)
65.54
+1.96 (+3.08%)
32.44
+0.65 (+2.04%)
293.99
+10.51 (+3.71%)
Find more stocks in the Stock Screener
HSY Latest News and Analysis
5 days ago - By: Chartmill
11 days ago - By: Chartmill
